Unverified50% confidenceOpinionExact time
The deployment of healthcare AI is moving from the phase of technical feasibility into the phase of payment and regulatory negotiation.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
9/26/2026
First Seen
Valid until: 12/25/2026
Sources
Related Entities
Related Claims
UnverifiedMedical AI has entered a new phase in which the capabilities of the model itself are no longer the primary bottleneck, and the challenge is shifting from whether the model can understand medicine to whether the model can integrate into medicine.72% similarUnverifiedAI has entered pharmaceutical segments including drug discovery, molecular screening, formulation development, real-world research, and pharmacovigilance.71% similarUnverified将AI技能存放在第三方云盘在金融、医疗等强监管行业存在合规风险69% similarUnverifiedThe demand for computing power in AI drug discovery and precision medicine is growing exponentially.69% similarUnverifiedWhen healthcare institutions evaluate AI solutions, they should focus on integration difficulty and implementation timelines in real clinical environments, deployment costs and long-term operation and maintenance investments, and the degree of adaptation to existing workflows and the acceptance level of medical staff.69% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/952734API
curl https://kongchang.com/api/v1/knowledge/claims/952734MCP
get_claim(id=952734)